Board Meetings for PFIZER

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
PFIZERPfizer Limited24 Jul 2014ResultsInter alia, to consider and take on record the Unaudited Financial Results of the Company for the 1st quarter ended June 30, 2014. Please be informed that the Trading Window for trading in the Equity shares of the Company will be closed from July 15, 2014 to July 25, 2014, both days inclusive.
-
PFIZERPfizer Limited02 May 2014Results/DividendInter alia, to consider and take on record the Audited Financial Results for the quarter January 1, 2014 to March 31, 2014 and for the year ended March 31, 2014. At the said meeting, the Board of Directors will also consider recommendation of final Dividend, if any, for the year ended March 31, 2014. The Trading Window for trading in the Equity shares of the Company is closed from April 23, 2014 to May 2, 2014, both days inclusive.
-
PFIZERPfizer Limited31 Jan 2014ResultsInter alia, to consider and take on record the Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2013.
-
PFIZERPfizer Limited23 Nov 2013OthersInter alia, to transact the following:(1) To consider a Scheme of Amalgamation of Wyeth Limited with the Company.(2) To consider declaration of Interim Dividend.
-
PFIZERPfizer Limited11 Nov 2013Resultsinter alia, to consider and take on record the Unaudited Financial Results of the Company for the second quarter and six months ended September 30, 2013.
PFIZERPfizer Limited26 Jul 2013ResultsInter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2013.
-
PFIZERPfizer Limited14 May 2013Board meeting RescheduledThe Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on May 03, 2013 To consider and take on record the Audited Financial Results for the quarter, January 1, 2013 to March 31, 2013 and the year ended March 31, 2013 and to consider recommendation of Dividend, if any, for the year ended March 31, 2013 and also informed dated May 03, 2013 about the postponement of the said Board Meeting. The Company has now informed the Exchange that a meeting of the Board of Directors of the Company will be held on May 14, 2013, inter alia, to consider and take on record the Audited Financial Results for the quarter, January 01, 2013 to March 31, 2013 and the year ended March 31, 2013. At the said meeting, the Board of Directors will also consider recommendation of Dividend, if any, for the year ended March 31, 2013.
-
PFIZERPfizer Limited03 May 2013Results/DividendTo consider and take on record the Audited Financial Results for the quarter, January 1, 2013 to March 31, 2013 and the year ended March 31, 2013 and to consider recommendation of Dividend, if any, for the year ended March 31, 2013.
PFIZERPfizer Limited07 Feb 2013ResultsInter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2012.
-
PFIZERPfizer Limited08 Nov 2012Un-audited Financial ResultsInter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2012.
-
PFIZERPfizer Limited13 Aug 2012Un-audited Financial ResultsInter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2012.
-
PFIZERPfizer Limited21 May 2012Results/DividendInter alia to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2012 and to recommend dividend thereon.
-
PFIZERPfizer Limited27 Jan 2012Un-audited Financial ResultsInter-alia to consider and approve the unaudited Financial Results of the Company for the 3rd quarter ended December 31, 2011.
-
PFIZERPfizer Limited24 Oct 2011Un-audited Financial ResultsInter-alia to consider and approve the Unaudited Financial Results of the Company for the 2nd quarter ended September 30, 2011.
-
PFIZERPfizer Limited01 Aug 2011Un-audited Financial ResultsInter-alia to consider and approve the Unaudited Financial Results of the Company for the 1st quarter ended June 30, 2011.
-
Showing page 5 of 7 (104 total items)